A Study of the Effect of Quizartinib on the Pharmacokinetics of the P-gp Substrate Dabigatran Etexilate in Healthy Participants

NCT04459585 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects
Drug-drug Interaction
Pharmacokinetics
Quizartinib

Interventions

DRUG: Dabigatran Etexilate Mesylate
DRUG: Quizartinib

Sponsor

Daiichi Sankyo Co., Ltd.